Clinical Trial

Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 9, 2023 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, the Quintuple method was applied for early intervention of prehepatic CTC-positive bowel cancer patients without dominant liver metastasis, aiming to explore the blocking effect of the Quintuple method on the metachronous liver metastases of colorectal cancer. A one-arm randomized clinical trial was conducted, and the patients were grouped according to their treatment methods. The patients with metachronous liver metastases were used as the end point of the experiment to evaluate the blocking effect of quintuple therapy.
Trial Details
NCT Number NCT05720559
Lead Sponsor Liaoning Cancer Hospital & Institute
Conditions Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
Enrollment 100 participants
Start Date 2023-03-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2023-02-09